Adjuvant Chemoradiation for Pathologic N2a Human Papillomavirus –Negative Head and Neck Cancer

This cohort study uses data from the National Cancer Database to assess whether adding chemotherapy to adjuvant radiation therapy is associated with improved survival among patients with human papillomavirus –negative head and neck squamous cell carcinoma with extranodal extension from a single lymph node smaller than 3 cm.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research